MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, KYNB made $6,440K in revenue. $183,452K in net income. Net profit margin of 2848.63%.

Income Overview

Revenue
$6,440K
Net Income
$183,452K
Net Profit Margin
2848.63%
EPS
$45.37
Unit: Thousand (K) dollars
Revenue Breakdown
    • Europe
    • JP
    • Development And Other Revenue

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-12-31
Total revenue
6,440
Cost of goods sold
556
Research and development
23,517
Selling, general and administrative
27,709
Restructuring charge
553
Total operating costs and expenses
52,335
Loss from operations
-45,895
Interest expense
8,759
Loss on debt extinguishments
-6,583
Interest income and other income (expenses), net
2,943
Total interest and other, net
-12,399
Loss from continuing operations before income taxes
-58,294
Benefit from income taxes
-90
Loss from continuing operations
-58,204
Product revenue, net
226,651
Cost of goods sold
13,454
Research and development
1,739
Selling, general and administrative
14,849
Total operating costs and expenses
30,042
Income from operations
196,609
Interest expense
7,816
Gain on divestiture
52,553
Interest income and other income (expenses), net
2,173
Total interest and other, net
-42,564
Income before income taxes
239,173
Provision for income taxes
0
Investment income in unconsolidated variable interest entity
2,483
Income from discontinued operations, net of tax
241,656
Net income (loss)
183,452
Basic EPS
45.37
Diluted EPS
45.37
Basic Average Shares
4,043,000
Diluted Average Shares
4,043,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Product revenue, net$226,651K Gain on divestiture$52,553K Income from operations$196,609K Total interest andother, net-$42,564K Total operating costsand expenses$30,042K Interest expense$7,816K Interest income and otherincome (expenses), net$2,173K Income before incometaxes$239,173K Investment income inunconsolidated variable...$2,483K Selling, general andadministrative$14,849K Cost of goods sold$13,454K Research and development$1,739K Income fromdiscontinued operations, net...$241,656K Net income (loss)$183,452K Loss from continuingoperations-$58,204K Benefit from incometaxes-$90K Europe$5,055K JP$793K Loss from continuingoperations before income...-$58,294K Drug Product Revenue$5,848K Development And OtherRevenue$592K Loss from operations-$45,895K Total interest andother, net-$12,399K Total revenue$6,440K Interest income and otherincome (expenses), net$2,943K Total operating costsand expenses$52,335K Interest expense$8,759K Loss on debtextinguishments-$6,583K Selling, general andadministrative$27,709K Research and development$23,517K Cost of goods sold$556K Restructuring charge$553K

KYNTRA BIO, INC. (KYNB)

KYNTRA BIO, INC. (KYNB)